Cancer Research AACR Legacy Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murakami, T.
Right arrow Articles by Hwang, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murakami, T.
Right arrow Articles by Hwang, S. T.
[Cancer Research 62, 7328-7334, December 2002]
© 2002 American Association for Cancer Research

Tumor Biology

Expression of CXC Chemokine Receptor-4 Enhances the Pulmonary Metastatic Potential of Murine B16 Melanoma Cells1

Takashi Murakami2, Wusi Maki2, Adela R. Cardones, Hui Fang, Adrian Tun Kyi, Frank O. Nestle and Sam T. Hwang3

Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892 [T. M., W. M., A. R. C., H. F., S. T. H.], and Department of Dermatology, University of Zürich Medical School, Zürich CH-8091, Switzerland [A. T. K., F. O. N.]

The chemokine receptors CC chemokine receptor (CCR) 7 and CXC chemokine receptor (CXCR) 4 have been implicated in cancer metastasis. To evaluate whether CXCR4 is sufficient to increase tumor metastasis in an organ-specific manner, we transduced murine B16 melanoma cells with CXCR4 (CXCR4-B16) and followed the metastatic fate of the transduced cells in both i.v. and s.c. inoculation models of metastasis. CXCR4-B16 cells demonstrated marked increases (>10-fold) in pulmonary metastasis compared with vector (pLNCX2)-B16 after i.v. and s.c. inoculation of tumor cells. The increase in metastasis could be completely inhibited by T22, a small peptide antagonist of CXCR4. As early as 24 and 48 h after i.v. injection, CXCR4-B16 cells were significantly increased in the lung compared with control B16 cells by 5- and 10-fold (P < 0.05), respectively. CXCR4-B16 cells adhered better to both dermal and pulmonary microvascular endothelial cells relative to control B16 cells. Moreover, CXCL12 promoted the growth of CXCR4-B16 cells in vitro. Whereas expression of CXCR4 in B16 cells dramatically enhanced pulmonary metastasis, metastasis to the lymph nodes, liver, and kidney was rare. Immunohistochemical staining of both primary human cutaneous melanoma and pulmonary metastases revealed CXCR4 expression. Thus, CXCR4 plays a potentially important role in promoting organ-selective metastasis, possibly by stimulating tumor adhesion to microvascular endothelial cells and by enhancing the growth of tumor cells under stress.




This article has been cited by other articles:


Home page
 BloodHome page
Y. Cui, H. Zhang, J. Meadors, R. Poon, M. Guimond, and C. L. Mackall
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
Blood, October 29, 2009; 114(18): 3831 - 3840.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
N. Cabioglu, A. A. Sahin, P. Morandi, F. Meric-Bernstam, R. Islam, H. Y. Lin, C. D. Bucana, A. M. Gonzalez-Angulo, G. N. Hortobagyi, and M. Cristofanilli
Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications
Ann. Onc., June 1, 2009; 20(6): 1013 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Molina-Ortiz, R. A. Bartolome, P. Hernandez-Varas, G. P. Colo, and J. Teixido
Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine-promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA
J. Biol. Chem., May 29, 2009; 284(22): 15147 - 15157.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Yanagisawa, I. Kadouchi, K. Yokomori, M. Hirose, M. Hakozaki, H. Hojo, K. Maeda, E. Kobayashi, and T. Murakami
Identification and Metastatic Potential of Tumor-Initiating Cells in Malignant Rhabdoid Tumor of the Kidney
Clin. Cancer Res., May 1, 2009; 15(9): 3014 - 3022.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
X. Ma, K. Norsworthy, N. Kundu, W. H. Rodgers, P. A. Gimotty, O. Goloubeva, M. Lipsky, Y. Li, D. Holt, and A. Fulton
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
Mol. Cancer Ther., March 1, 2009; 8(3): 490 - 498.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. A. Bartolome, S. Ferreiro, M. E. Miquilena-Colina, L. Martinez-Prats, M. L. Soto-Montenegro, D. Garcia-Bernal, J. J. Vaquero, R. Agami, R. Delgado, M. Desco, et al.
The Chemokine Receptor CXCR4 and the Metalloproteinase MT1-MMP Are Mutually Required during Melanoma Metastasis to Lungs
Am. J. Pathol., February 1, 2009; 174(2): 602 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. J. Chien, E. C. Moore, A. S. Lonsdorf, R. M. Kulikauskas, B. G. Rothberg, A. J. Berger, M. B. Major, S. T. Hwang, D. L. Rimm, and R. T. Moon
Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
PNAS, January 27, 2009; 106(4): 1193 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Wong and W. Korz
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Clin. Cancer Res., December 15, 2008; 14(24): 7975 - 7980.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. He, L. Fang, J. Wang, Y. Yi, S. Zhang, and X. Xie
Bryostatin-5 Blocks Stromal Cell-Derived Factor-1 Induced Chemotaxis via Desensitization and Down-regulation of Cell Surface CXCR4 Receptors
Cancer Res., November 1, 2008; 68(21): 8678 - 8686.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. A. Bartolome, N. Wright, I. Molina-Ortiz, F. J. Sanchez-Luque, and J. Teixido
Activated G{alpha}13 Impairs Cell Invasiveness through p190RhoGAP-Mediated Inhibition of RhoA Activity
Cancer Res., October 15, 2008; 68(20): 8221 - 8230.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Abrams, P. C. Lee, J. L. Port, N. K. Altorki, and A. I. Neugut
Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2707 - 2713.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C.-T. Tan, C.-Y. Chu, Y.-C. Lu, C.-C. Chang, B.-R. Lin, H.-H. Wu, H.-L. Liu, S.-T. Cha, E. Prakash, J.-Y. Ko, et al.
CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway
Carcinogenesis, August 1, 2008; 29(8): 1519 - 1527.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E. S. Witze, E. S. Litman, G. M. Argast, R. T. Moon, and N. G. Ahn
Wnt5a Control of Cell Polarity and Directional Movement by Polarized Redistribution of Adhesion Receptors
Science, April 18, 2008; 320(5874): 365 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. de Nigris, R. Rossiello, C. Schiano, C. Arra, S. Williams-Ignarro, A. Barbieri, A. Lanza, A. Balestrieri, M. T. Giuliano, L. J. Ignarro, et al.
Deletion of Yin Yang 1 Protein in Osteosarcoma Cells on Cell Invasion and CXCR4/Angiogenesis and Metastasis
Cancer Res., March 15, 2008; 68(6): 1797 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Xu, J. Sui, H. Tao, Q. Zhu, and W. A. Marasco
Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Define CXCR4 Antigenic Heterogeneity
J. Immunol., August 15, 2007; 179(4): 2408 - 2418.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
K. Otto, H. Starz, J. C. Becker, and D. Schrama
Overexpression of Matrix Metalloproteinases, Chemokines, and Chemokine Receptors Relevant for Metastasis in Experimental Models Not an Indication of Lymph Node Metastases in Human Melanoma
Arch Dermatol, July 1, 2007; 143(7): 947 - 948.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Petty, V. Sueblinvong, C. C. Lenox, C. C. Jones, G. P. Cosgrove, C. D. Cool, P. R. Rai, K. K. Brown, D. J. Weiss, M. E. Poynter, et al.
Pulmonary Stromal-Derived Factor-1 Expression and Effect on Neutrophil Recruitment during Acute Lung Injury
J. Immunol., June 15, 2007; 178(12): 8148 - 8157.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C.-h. Lee, T. Kakinuma, J. Wang, H. Zhang, D. C. Palmer, N. P. Restifo, and S. T. Hwang
Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.
Mol. Cancer Ther., October 1, 2006; 5(10): 2592 - 2599.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Sato, M. Ohtsuki, M. Hata, E. Kobayashi, and T. Murakami
Antitumor Activity of IFN-{lambda} in Murine Tumor Models.
J. Immunol., June 15, 2006; 176(12): 7686 - 7694.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Andre, N. Cabioglu, H. Assi, J. C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J. P. Spano, C. Combadiere, C. Bucana, et al.
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer
Ann. Onc., June 1, 2006; 17(6): 945 - 951.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Scala, P. Giuliano, P. A. Ascierto, C. Ierano, R. Franco, M. Napolitano, A. Ottaiano, M. L. Lombardi, M. Luongo, E. Simeone, et al.
Human Melanoma Metastases Express Functional CXCR4
Clin. Cancer Res., April 15, 2006; 12(8): 2427 - 2433.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. Kakinuma and S. T. Hwang
Chemokines, chemokine receptors, and cancer metastasis
J. Leukoc. Biol., April 1, 2006; 79(4): 639 - 651.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. A. Bartolome, I. Molina-Ortiz, R. Samaniego, P. Sanchez-Mateos, X. R. Bustelo, and J. Teixido
Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase-Dependent Melanoma Cell Invasion
Cancer Res., January 1, 2006; 66(1): 248 - 258.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. T. Kaifi, E. F. Yekebas, P. Schurr, D. Obonyo, R. Wachowiak, P. Busch, A. Heinecke, K. Pantel, and J. R. Izbicki
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
J Natl Cancer Inst, December 21, 2005; 97(24): 1840 - 1847.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Burger, T. Hartmann, M. Krome, J. Rawluk, H. Tamamura, N. Fujii, T. J. Kipps, and J. A. Burger
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
Blood, September 1, 2005; 106(5): 1824 - 1830.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Guleng, K. Tateishi, M. Ohta, F. Kanai, A. Jazag, H. Ijichi, Y. Tanaka, M. Washida, K. Morikane, Y. Fukushima, et al.
Blockade of the Stromal Cell-Derived Factor-1/CXCR4 Axis Attenuates In vivo Tumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor-Independent Manner
Cancer Res., July 1, 2005; 65(13): 5864 - 5871.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Hu, X. Deng, X. Bian, G. Li, Y. Tong, Y. Li, Q. Wang, R. Xin, X. He, G. Zhou, et al.
The Expression of Functional Chemokine Receptor CXCR4 Is Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma
Clin. Cancer Res., July 1, 2005; 11(13): 4658 - 4665.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Laverdiere, B. H. Hoang, R. Yang, R. Sowers, J. Qin, P. A. Meyers, A. G. Huvos, J. H. Healey, and R. Gorlick
Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma
Clin. Cancer Res., April 1, 2005; 11(7): 2561 - 2567.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Mori, J. Kim, T. Yamano, H. Takeuchi, S. Huang, N. Umetani, K. Koyanagi, and D. S.B. Hoon
Epigenetic Up-regulation of C-C Chemokine Receptor 7 and C-X-C Chemokine Receptor 4 Expression in Melanoma Cells
Cancer Res., March 1, 2005; 65(5): 1800 - 1807.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. C. Schimanski, S. Schwald, N. Simiantonaki, C. Jayasinghe, U. Gonner, V. Wilsberg, T. Junginger, M. R. Berger, P. R. Galle, and M. Moehler
Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer
Clin. Cancer Res., March 1, 2005; 11(5): 1743 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Scala, A. Ottaiano, P. A. Ascierto, M. Cavalli, E. Simeone, P. Giuliano, M. Napolitano, R. Franco, G. Botti, and G. Castello
Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma
Clin. Cancer Res., March 1, 2005; 11(5): 1835 - 1841.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Perissinotto, G. Cavalloni, F. Leone, V. Fonsato, S. Mitola, G. Grignani, N. Surrenti, D. Sangiolo, F. Bussolino, W. Piacibello, et al.
Involvement of Chemokine Receptor 4/Stromal Cell-Derived Factor 1 System during Osteosarcoma Tumor Progression
Clin. Cancer Res., January 15, 2005; 11(2): 490 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. F. Fraga, M. Herranz, J. Espada, E. Ballestar, M. F. Paz, S. Ropero, E. Erkek, O. Bozdogan, H. Peinado, A. Niveleau, et al.
A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human Tumors
Cancer Res., August 15, 2004; 64(16): 5527 - 5534.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. G. Vaday, S.-B. Hua, D. M. Peehl, M. H. Pauling, Y.-H. Lin, L. Zhu, D. M. Lawrence, H. D. Foda, and S. Zucker
CXCR4 and CXCL12 (SDF-1) in Prostate Cancer: Inhibitory Effects of Human Single Chain Fv Antibodies
Clin. Cancer Res., August 15, 2004; 10(16): 5630 - 5639.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, T. Manabe, K. Inaba, N. Minato, M. Oshima, and M. M. Taketo
Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes
Cancer Res., June 1, 2004; 64(11): 4010 - 4017.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. S. Haviv, W. J. van Houdt, B. Lu, D. T. Curiel, and Z. B. Zhu
Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter
Mol. Cancer Ther., June 1, 2004; 3(6): 687 - 691.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J.-P. Spano, F. Andre, L. Morat, L. Sabatier, B. Besse, C. Combadiere, P. Deterre, A. Martin, J. Azorin, D. Valeyre, et al.
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome
Ann. Onc., April 1, 2004; 15(4): 613 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. A. Bartolome, B. G. Galvez, N. Longo, F. Baleux, G. N. P. van Muijen, P. Sanchez-Mateos, A. G. Arroyo, and J. Teixido
Stromal Cell-Derived Factor-1{alpha} Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities
Cancer Res., April 1, 2004; 64(7): 2534 - 2543.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Yao, O. Salvucci, A. R. Cardones, S. T. Hwang, Y. Aoki, M. De La Luz Sierra, A. Sajewicz, S. Pittaluga, R. Yarchoan, and G. Tosato
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis
Blood, December 1, 2003; 102(12): 3900 - 3905.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. Murakami, A. R. Cardones, S. E. Finkelstein, N. P. Restifo, B. A. Klaunberg, F. O. Nestle, S. S. Castillo, P. A. Dennis, and S. T. Hwang
Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
J. Exp. Med., November 3, 2003; 198(9): 1337 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. R. Cardones, T. Murakami, and S. T. Hwang
CXCR4 Enhances Adhesion of B16 Tumor Cells to Endothelial Cells in Vitro and in Vivo via {beta}1 Integrin
Cancer Res., October 15, 2003; 63(20): 6751 - 6757.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Helbig, K. W. Christopherson II, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K. D. Miller, H. E. Broxmeyer, and H. Nakshatri
NF-{kappa} B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
J. Biol. Chem., June 6, 2003; 278(24): 21631 - 21638.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.